Bessemer Group’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$63K Sell
596
-227
-28% -$27.5K ﹤0.01% 1632
2026
Q1
$135K Sell
823
-145
-15% -$22.3K ﹤0.01% 1473
2025
Q4
$168K Buy
968
+132
+16% +$24.1K ﹤0.01% 1383
2025
Q3
$121K Buy
836
+484
+138% +$59.3K ﹤0.01% 1240
2025
Q2
$35K Buy
352
+35
+11% +$2.68K ﹤0.01% 1406
2025
Q1
$24K Sell
317
-18
-5% -$1.38K ﹤0.01% 1482
2024
Q4
$23K Buy
335
+35
+12% +$2.52K ﹤0.01% 1475
2024
Q3
$22K Buy
300
+140
+88% +$10.3K ﹤0.01% 1484
2024
Q2
$11K Buy
+160
New +$6.21K ﹤0.01% 1493
2022
Q2
Sell
-248
Closed -$6K 1947
2022
Q1
$6K Hold
248
﹤0.01% 1475
2021
Q4
$7K Hold
248
﹤0.01% 1495
2021
Q3
$7K Hold
248
﹤0.01% 1451
2021
Q2
$7K Hold
248
﹤0.01% 1390
2021
Q1
$8K Buy
+248
New +$9.48K ﹤0.01% 1344
2014
Q2
Sell
-4,728
Closed -$90K 1439
2014
Q1
$90K Buy
+4,728
New +$89.8K ﹤0.01% 753

Other funds holding INSM

Bessemer Group's INSM Position: Q2 2026 in Review

Bessemer Group reduced its Insmed (INSM) stake by 28% in Q2 2026, selling an estimated $27.5K and leaving 596 shares worth $63K. The position accounts for ﹤0.01% of the portfolio, ranked #1632.

Bessemer Group first reported a position in INSM in Q1 2014 and has held it in 15 quarters since. The position peaked at $168K in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Bessemer Group held 596 shares of Insmed worth $63K as of Q2 2026.
  • Bessemer Group sold 227 Insmed shares in Q2 2026, an estimated $27.5K.
  • Insmed made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #1632 holding.
  • Bessemer Group first reported a position in Insmed in Q1 2014 and has held it in 15 quarters since.
  • Bessemer Group's Insmed position peaked at $168K in Q4 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.